$REGN
REGENERON PHARMACEUTICALS, INC.

2024 Q3 Form 10-Q Financial Statement

#000180422024000040 Filed on October 31, 2024

View on sec.gov

Income Statement

Concept 2024 Q3
Revenue $3.721B
YoY Change 10.65%
Cost Of Revenue $491.1M
YoY Change 12.53%
Gross Profit $3.230B
YoY Change 10.36%
Gross Profit Margin 86.8%
Selling, General & Admin $714.4M
YoY Change 11.54%
% of Gross Profit 22.12%
Research & Development $1.272B
YoY Change 18.25%
% of Gross Profit 39.37%
Depreciation & Amortization $121.7M
YoY Change 15.46%
% of Gross Profit 3.77%
Operating Expenses $1.986B
YoY Change 15.74%
Operating Profit $1.180B
YoY Change 6.17%
Interest Expense $308.1M
YoY Change 1630.9%
% of Operating Profit 26.12%
Other Income/Expense, Net $313.5M
YoY Change -156850.0%
Pretax Income $1.493B
YoY Change 34.41%
Income Tax $152.4M
% Of Pretax Income 10.21%
Net Earnings $1.341B
YoY Change 33.02%
Net Earnings / Revenue 36.03%
Basic Earnings Per Share $12.40
Diluted Earnings Per Share $11.54
COMMON SHARES
Basic Shares Outstanding 108.1M shares
Diluted Shares Outstanding 116.2M shares

Balance Sheet

Concept 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.797B
YoY Change -1.19%
Cash & Equivalents $2.012B
Short-Term Investments $7.785B
Other Short-Term Assets $412.0M
YoY Change -28.35%
Inventory $3.018B
Prepaid Expenses
Receivables $6.107B
Other Receivables $0.00
Total Short-Term Assets $19.33B
YoY Change 3.75%
LONG-TERM ASSETS
Property, Plant & Equipment $4.439B
YoY Change 10.81%
Goodwill
YoY Change
Intangibles $1.120B
YoY Change 10.12%
Long-Term Investments $8.491B
YoY Change 45.42%
Other Assets $1.043B
YoY Change 154.45%
Total Long-Term Assets $18.11B
YoY Change 33.85%
TOTAL ASSETS
Total Short-Term Assets $19.33B
Total Long-Term Assets $18.11B
Total Assets $37.44B
YoY Change 16.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $497.3M
YoY Change -7.32%
Accrued Expenses $2.537B
YoY Change -4.1%
Deferred Revenue $627.2M
YoY Change 50.3%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.661B
YoY Change 1.73%
LONG-TERM LIABILITIES
Long-Term Debt $1.984B
YoY Change 0.07%
Other Long-Term Liabilities $1.544B
YoY Change 85.44%
Total Long-Term Liabilities $3.528B
YoY Change 25.31%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.661B
Total Long-Term Liabilities $3.528B
Total Liabilities $8.116B
YoY Change 11.81%
SHAREHOLDERS EQUITY
Retained Earnings $30.76B
YoY Change 17.83%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $29.33B
YoY Change
Total Liabilities & Shareholders Equity $37.44B
YoY Change 16.41%

Cashflow Statement

Concept 2024 Q3
OPERATING ACTIVITIES
Net Income $1.341B
YoY Change 33.02%
Depreciation, Depletion And Amortization $121.7M
YoY Change 15.46%
Cash From Operating Activities $1.291B
YoY Change 15.88%
INVESTING ACTIVITIES
Capital Expenditures $241.9M
YoY Change 21.01%
Acquisitions
YoY Change
Other Investing Activities -$332.5M
YoY Change 12.18%
Cash From Investing Activities -$574.4M
YoY Change 15.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -634.0M
YoY Change 55.66%
NET CHANGE
Cash From Operating Activities 1.291B
Cash From Investing Activities -574.4M
Cash From Financing Activities -634.0M
Net Change In Cash 82.80M
YoY Change -60.7%
FREE CASH FLOW
Cash From Operating Activities $1.291B
Capital Expenditures $241.9M
Free Cash Flow $1.049B
YoY Change 14.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0000872589
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Trading Symbol
TradingSymbol
REGN
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
7784700000 usd
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
8114800000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6107100000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5667300000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
3018000000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
2580500000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
412000000.0 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1543600000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
854100000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
8116000000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
7107100000 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000.0 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000.0 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
12702800000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11354000000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
27260300000 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
60200000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3720700000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3362700000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10412800000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9682900000 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1271500000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1075300000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3719900000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3261800000 usd
us-gaap Costs And Expenses
CostsAndExpenses
6608700000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1179500000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1111000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
3000500000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
3074200000 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
327300000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
17600000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
866000000.0 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
313500000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-200000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
821300000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-22500000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1493000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3821800000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3051700000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
152400000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
103000000.0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
326900000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
257700000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
1340600000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1007800000 usd
us-gaap Net Income Loss
NetIncomeLoss
3494900000 usd
us-gaap Net Income Loss
NetIncomeLoss
2794000000 usd
us-gaap Net Income Loss
NetIncomeLoss
3494900000 usd
us-gaap Net Income Loss
NetIncomeLoss
2794000000 usd
CY2024Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
128200000 usd
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
21300000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
139600000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
62800000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
386600000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
19333600000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
19479200000 usd
CY2024Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
8490900000 usd
CY2023Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
5396500000 usd
CY2024Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
4439200000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
4146400000 usd
CY2024Q3 us-gaap Assets
Assets
37441900000 usd
CY2023Q4 us-gaap Assets
Assets
33080200000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
497300000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
606600000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
30755200000 usd
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
25500000 shares
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
32200000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1110800000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
12.40
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
9.48
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
32.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
26.16
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
11.54
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
8.89
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
30.23
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
108100000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
106300000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
116200000 shares
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2160200000 usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
24.57
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1007800000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1470700000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1028700000 usd
CY2024Q1 regn Stock Issued Distributed During Period Value Employee Benefit Plan
StockIssuedDistributedDuringPeriodValueEmployeeBenefitPlan
20500000 usd
CY2024Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
298000000.0 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
233300000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
26991100000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
436500000 usd
CY2024Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
311800000 usd
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-19034
dei Entity Registrant Name
EntityRegistrantName
REGENERON PHARMACEUTICALS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3444607
dei Entity Address Address Line1
EntityAddressAddressLine1
777 Old Saw Mill River Road
dei Entity Address City Or Town
EntityAddressCityOrTown
Tarrytown
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10591-6707
dei City Area Code
CityAreaCode
914
dei Local Phone Number
LocalPhoneNumber
847-7000
dei Security12b Title
Security12bTitle
Common Stock - par value $.001 per share
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2011800000 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1120100000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1038600000 usd
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
3015100000 usd
CY2024Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
2536500000 usd
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
2357900000 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
627200000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3661000000 usd
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-80900000 usd
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
27000000.0 shares
CY2024Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
14192400000 usd
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
12560400000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
29325900000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
458900000 usd
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
126700000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
25973100000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
37441900000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
33080200000 usd
CY2024Q3 regn Acquired In Process Research And Development
AcquiredInProcessResearchAndDevelopment
56200000 usd
CY2023Q3 regn Acquired In Process Research And Development
AcquiredInProcessResearchAndDevelopment
100000000.0 usd
regn Acquired In Process Research And Development
AcquiredInProcessResearchAndDevelopment
87200000 usd
regn Acquired In Process Research And Development
AcquiredInProcessResearchAndDevelopment
156100000 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
714400000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
640500000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2162200000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1893600000 usd
CY2024Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-8000000.0 usd
CY2023Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
500000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-37900000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
1600000 usd
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
2541200000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
2251700000 usd
us-gaap Costs And Expenses
CostsAndExpenses
7412300000 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
13800000 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
17800000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
44700000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
54700000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
108000000.0 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
106800000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
113400000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115600000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
113700000 shares
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
1340600000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3636000000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
25973100000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
672400000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
722000000.0 usd
CY2024Q2 regn Stock Issued Distributed During Period Value Employee Benefit Plan
StockIssuedDistributedDuringPeriodValueEmployeeBenefitPlan
21800000 usd
CY2024Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
601400000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
230000000.0 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
1432300000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
28205800000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
22664000000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
491300000 usd
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2730000000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2575400000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1043000000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
444100000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3423400000 usd
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1984000000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1982900000 usd
CY2024Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
720000000.0 usd
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
720000000.0 usd
CY2024Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
207400000 usd
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
1900000 usd
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-400000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
1500000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-800000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2856000000 usd
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
335900000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3700000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
7300000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
255700000 usd
CY2024Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
120200000 usd
CY2024Q3 regn Stock Issued Distributed During Period Value Employee Benefit Plan
StockIssuedDistributedDuringPeriodValueEmployeeBenefitPlan
21800000 usd
CY2024Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
738300000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
230400000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
1340600000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
130100000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
29325900000 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
99200000 usd
CY2023Q1 regn Stock Issued Distributed During Period Value Employee Benefit Plan
StockIssuedDistributedDuringPeriodValueEmployeeBenefitPlan
20600000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
693900000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
237400000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
817800000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
57200000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
23495200000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
80700000 usd
CY2023Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
14000000.0 usd
CY2023Q2 regn Stock Issued Distributed During Period Value Employee Benefit Plan
StockIssuedDistributedDuringPeriodValueEmployeeBenefitPlan
18500000 usd
CY2023Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
722800000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
208000000.0 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
968400000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-16100000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
24017900000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
268900000 usd
CY2023Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
129400000 usd
CY2023Q3 regn Stock Issued Distributed During Period Value Employee Benefit Plan
StockIssuedDistributedDuringPeriodValueEmployeeBenefitPlan
18000000.0 usd
CY2023Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
507100000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
207400000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1007800000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
20900000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
24904400000 usd
us-gaap Net Income Loss
NetIncomeLoss
3494900000 usd
us-gaap Net Income Loss
NetIncomeLoss
2794000000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
356500000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
308000000.0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
678400000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
644600000 usd
regn Marketable And Other Securities Gain Loss
MarketableAndOtherSecuritiesGainLoss
331200000 usd
regn Marketable And Other Securities Gain Loss
MarketableAndOtherSecuritiesGainLoss
-324500000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
31900000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-17400000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
477100000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
551500000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
436200000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
256100000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
502000000.0 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
224400000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
352200000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
284400000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
249000000.0 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-5100000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
509500000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
737300000 usd
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-337200000 usd
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
710300000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3157700000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3504300000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
14664500000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
9514200000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
12445300000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
7059300000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
556300000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
467200000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
20100000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
regn Payments To Acquire Intangible Assets1
PaymentsToAcquireIntangibleAssets1
58300000 usd
regn Payments To Acquire Intangible Assets1
PaymentsToAcquireIntangibleAssets1
145700000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
5000000.0 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
51100000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2818700000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3118900000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1374400000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
844500000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
775700000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
242500000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1630300000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1946000000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-33400000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1065000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1344000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-600000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-726000000.0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-959200000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2737800000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3119400000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2011800000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
1340600000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1007800000 usd
us-gaap Net Income Loss
NetIncomeLoss
3494900000 usd
us-gaap Net Income Loss
NetIncomeLoss
2794000000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
108100000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
106300000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
108000000.0 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
106800000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
116200000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
113400000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115600000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
113700000 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
12.40
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
9.48
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
32.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
26.16
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
11.54
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
8.89
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
30.23
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
24.57
CY2024Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
14892600000 usd
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
100800000 usd
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
26000000.0 usd
CY2024Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
14967400000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
12636000000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
13700000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
115800000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
12533900000 usd
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
7784700000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
8114800000 usd
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
7181900000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
4414500000 usd
CY2024Q3 regn Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date After Year5
DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYear5
800000 usd
CY2023Q4 regn Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date After Year5
DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYear5
4600000 usd
CY2024Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
14967400000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
12533900000 usd
CY2024Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
12339200000 usd
CY2024Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
800000 usd
CY2024Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
1667500000 usd
CY2024Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
25200000 usd
CY2024Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
14006700000 usd
CY2024Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
26000000.0 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
7854900000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
9000000.0 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
4157500000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
106800000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
12012400000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
115800000 usd
CY2024Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
159800000 usd
CY2023Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
74300000 usd
CY2024Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
134500000 usd
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
330800000 usd
CY2023Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-100300000 usd
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-295900000 usd
CY2023Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
29000000 usd
CY2024Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
856600000 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
789300000 usd
CY2024Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1230100000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1121800000 usd
CY2024Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
164600000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
147300000 usd
CY2024Q3 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
766700000 usd
CY2023Q4 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
522100000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
3018000000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
2580500000 usd
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.102
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.093
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.086
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.084
CY2024Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
600000 shares
CY2023Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
700000 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1500000 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
2600000 shares
CY2024Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
738300000 usd
CY2023Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
507100000 usd
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1637700000 usd
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1923800000 usd
CY2024Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
2893000000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2011800000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2152300000 usd
CY2024Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
0 usd
CY2023Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
7900000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2011800000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2160200000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
94000000.0 usd
CY2023 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
75400000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
98900000 usd
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
70800000 usd
regn Acquisitions Contingent Consideration Accrued But Not Yet Paid
AcquisitionsContingentConsiderationAccruedButNotYetPaid
88000000.0 usd
CY2023 regn Acquisitions Contingent Consideration Accrued But Not Yet Paid
AcquisitionsContingentConsiderationAccruedButNotYetPaid
71600000 usd
regn Acquisitions Contingent Consideration Accrued But Not Yet Paid
AcquisitionsContingentConsiderationAccruedButNotYetPaid
106500000 usd
CY2022 regn Acquisitions Contingent Consideration Accrued But Not Yet Paid
AcquisitionsContingentConsiderationAccruedButNotYetPaid
135500000 usd
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
0001804220-24-000040-index-headers.html Edgar Link pending
0001804220-24-000040-index.html Edgar Link pending
0001804220-24-000040.txt Edgar Link pending
0001804220-24-000040-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
regn-20240930.htm Edgar Link pending
regn-20240930.xsd Edgar Link pending
regn-ex_101x9302024x10q.htm Edgar Link pending
regn-ex_311x09302024x10q.htm Edgar Link pending
regn-ex_312x09302024x10q.htm Edgar Link pending
regn-ex_32x09302024.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
regn-20240930_lab.xml Edgar Link unprocessable
regn-20240930_pre.xml Edgar Link unprocessable
regn-20240930_cal.xml Edgar Link unprocessable
regn-20240930_def.xml Edgar Link unprocessable
regn-20240930_htm.xml Edgar Link completed